Laparoscopic Ventral Mesh Rectopexy Versus Trans-vaginal Repair for Anterior Rectocele. (NCT06633172) | Clinical Trial Compass
CompletedNot Applicable
Laparoscopic Ventral Mesh Rectopexy Versus Trans-vaginal Repair for Anterior Rectocele.
Egypt40 participantsStarted 2021-04-01
Plain-language summary
This study aims to compare the effect of laparoscopic ventral mesh rectopexy versus trans vaginal repair in management of anterior rectocele in females regarding functional outcomes.
Who can participate
Age range30 Years – 60 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Female patients aged between 30 and 60 years, presented with symptomatic rectocele with failed conservative treatments.
* anterior rectocele larger than 3 cm in size with retention of the contrast in the rectocele on defecography.
* excessive straining, sense of incomplete evacuation, the need for digital manipulation during defecation, or dyspareunia.
Exclusion Criteria:
* significant urinary manifestations due to anterior vaginal wall prolapse.
* patients with recurrent rectocele
* complete external rectal prolapse
* isolated anismus
* connective tissue disease
* patients with slow-transit constipation
* fecal incontinence (FI), or abnormal thyroid function.